P3‐301: Dextromethorphan/quinidine (AVP‐923) phase 2 study for treatment of agitation in Alzheimer's disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440). (1st July 2015)

• Record Type: Journal Article
• Authors: Cummings, Jeffrey L.; Lyketsos, Constantine; Peskind, Elaine R.; Porsteinsson, Anton P.; Mintzer, Jacobo E.; Scharre, Douglas W.; De La Gándara, José E.; Agronin, Marc; Davis, Charles S.; Nguyen, Uyen; Shin, Paul; Tariot, Pierre N.; Siffert, Joao
• Is Part Of: Alzheimer's & dementia. Volume 11(2015)Supplement 7:Part 16
• Page Start: P751
• Page End: P751
• Publication Date: 2015-07-01
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1016/j.jalz.2015.06.1675
• Languages: English
• ISSNs: 1552-5260